|
C22ORF28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.88149999603394E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.09069999998379E-06 |
| Normal-vs-Stage2 |
4.595900E-02 |
| Normal-vs-Stage3 |
3.036800E-03 |
| Normal-vs-Stage4 |
1.52092999999853E-05 |
| Stage1-vs-Stage2 |
5.391000E-01 |
| Stage1-vs-Stage3 |
8.765400E-01 |
| Stage1-vs-Stage4 |
1.731780E-01 |
| Stage2-vs-Stage3 |
5.473800E-01 |
| Stage2-vs-Stage4 |
1.126020E-01 |
| Stage3-vs-Stage4 |
2.621600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81170000002062E-07 |
| Normal-vs-AfricanAmerican |
1.96773999999733E-05 |
| Normal-vs-Asian |
5.742000E-02 |
| Caucasian-vs-AfricanAmerican |
9.586000E-01 |
| Caucasian-vs-Asian |
2.730400E-01 |
| AfricanAmerican-vs-Asian |
1.850560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7791999999961E-06 |
| Normal-vs-Female |
2.25560004007974E-09 |
| Male-vs-Female |
1.983950E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.28359999693484E-08 |
| Normal-vs-Extreme_Weight |
2.58070000036525E-07 |
| Normal-vs-Obese |
3.522500E-03 |
| Normal-vs-Extreme_Obese |
6.642400E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.111200E-01 |
| Normal_Weight-vs-Obese |
4.202400E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.516600E-01 |
| Extreme_Weight-vs-Obese |
2.008800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.119400E-01 |
| Obese-vs-Extreme_Obese |
5.058200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.128330E-02 |
| Normal-vs-Age(41-60Yrs) |
1.77339999996029E-06 |
| Normal-vs-Age(61-80Yrs) |
6.17139999992133E-07 |
| Normal-vs-Age(81-100Yrs) |
1.234690E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.519000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.190400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.418200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.543600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.001600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.552400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.1226999997489E-07 |
| Normal-VS-Type2 PRCC |
2.075600E-02 |
| Normal-VS-KIRP CIMP |
1.70859999482076E-08 |
| Normal-VS-Unclassified PRCC |
3.30829999950488E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.436400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.317100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.341600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.620000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.701800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.573800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.418500E-04 |
| Normal-vs-N1 |
1.021230E-04 |
| Normal-vs-N2 |
2.326200E-01 |
| N0-vs-N1 |
2.982800E-01 |
| N0-vs-N2 |
6.486000E-01 |
| N1-vs-N2 |
9.878400E-01 |
|
|
